TETRAPHASE PHARMACEUTICALS I's ticker is and the CUSIP is 88165N955. A total of 3 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -69.2% | 7,900 | -20.2% | 0.00% | – |
| Q1 2019 | $13,000 | +30.0% | 9,900 | +10.0% | 0.00% | – |
| Q4 2018 | $10,000 | -93.0% | 9,000 | -82.6% | 0.00% | -100.0% |
| Q3 2018 | $143,000 | -31.9% | 51,700 | -11.9% | 0.00% | -50.0% |
| Q2 2018 | $210,000 | +517.6% | 58,700 | +433.6% | 0.00% | – |
| Q1 2018 | $34,000 | -96.4% | 11,000 | -92.7% | 0.00% | -100.0% |
| Q4 2017 | $948,000 | -65.5% | 150,400 | -62.5% | 0.01% | -72.0% |
| Q3 2017 | $2,744,000 | +693.1% | 401,200 | +727.2% | 0.02% | +525.0% |
| Q2 2017 | $346,000 | -15.2% | 48,500 | +9.2% | 0.00% | -20.0% |
| Q1 2017 | $408,000 | +10100.0% | 44,400 | +4833.3% | 0.01% | – |
| Q4 2016 | $4,000 | -97.9% | 900 | -98.2% | 0.00% | -100.0% |
| Q3 2016 | $195,000 | -10.1% | 51,000 | +1.0% | 0.00% | -33.3% |
| Q2 2016 | $217,000 | -32.0% | 50,500 | -26.6% | 0.00% | -40.0% |
| Q1 2016 | $319,000 | -16.7% | 68,800 | +80.1% | 0.01% | 0.0% |
| Q4 2015 | $383,000 | -55.9% | 38,200 | -67.2% | 0.01% | -58.3% |
| Q3 2015 | $868,000 | -31.2% | 116,400 | +337.6% | 0.01% | -33.3% |
| Q2 2015 | $1,262,000 | +144.1% | 26,600 | +88.7% | 0.02% | +125.0% |
| Q1 2015 | $517,000 | -60.9% | 14,100 | -57.7% | 0.01% | -60.0% |
| Q4 2014 | $1,322,000 | +15.9% | 33,300 | -41.8% | 0.02% | +11.1% |
| Q3 2014 | $1,141,000 | +136.2% | 57,200 | +59.8% | 0.02% | +157.1% |
| Q2 2014 | $483,000 | +286.4% | 35,800 | +211.3% | 0.01% | +250.0% |
| Q1 2014 | $125,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 68,800 | $319,000 | 0.01% |
| SIMPLEX TRADING, LLC | 144 | $60,000 | 0.01% |
| Citadel Advisors | 37,700 | $175,000 | 0.00% |